In Liu et al.'s [29] study they found that CD90 had specificity of 91.9% for HCC and sensibility of 48.22% in predicting low differentiation, which demonstrated that CD90 was a promising target for patients with HCC. Here, THY1 is linked to hepatocellular carcinoma.